|
⚲
|
| Keyboard |
| Cue Biopharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001645460 |
| Sale | 2026-07-13 (50.0 M Offered, 50.0 M Sold) |
| Fund | |
| Phone | 6179492680 |
| Address | 40 Guest Street Boston, MA 02135 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-07-22 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| In the News | |
|---|---|
| Tue, 30 Jun 2026 | Cue Biopharma (NASDAQ:CUE) Stock Price Up 19.9% – What's Next? — dailypolitical.com |
| Tue, 30 Jun 2026 | Cue Biopharma (NASDAQ:CUE) Stock Price Up 19.9% – Here's What Happened — tickerreport.com |
| Tue, 12 May 2026 | Short Interest in Cue Biopharma, Inc. (NASDAQ:CUE) Drops By 96.2% — tickerreport.com |
| Mon, 20 Apr 2026 | Cue Biopharma (CUE) Appoints Lucinda Warren as Interim President and CEO — yahoo.com |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Michael Meluzio | Executive Officer | |
| Pasha Sarraf | Director | |
| Viola Meehan | Director | |
| Pamela Garzone | Director | |
| Daniel Camardo | Director | |
| Sumita Ray | Executive Officer | |
| Dominic Borie | Executive Officer | |
| Shaolee Lin | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
SKKY Partners LP
✚
|
MA | |
|
Link Ventures Management LLC
✚
|
MA | |
|
HSV Holdings LLC
✚
|
MA | |
|
Cataria Capital Management LP
✚
|
MA | |
|
Thomas H Lee Partners LP
✚
|
MA | |
|
First Star Ventures LLC
✚
|
MA | |
|
Boston Global Ventures LLC
✚
|
MA | |
|
Quantopian Management LP
✚
|
MA | |
|
Constitution Capital Horizon Advisor LP
✚
|
MA | |
|
Calvert Capital Management Company
✚
|
MA |